The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Oralair 300 IR
ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN · POA PRATENSIS POLLEN 300 [IR]/1; DACTYLIS GLOMERATA POLLEN 300 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1 · Tablet, Orally Disintegrating · Sublingual · Stallergenes
NDC 59617-0016-01 · 1 BLISTER PACK in 1 BOX / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · BLA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BLA125471
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN (Tablet, Orally Disintegrating)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cenexi Hsc | DACTYLIS GLOMERATA POLLEN 300 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | DACTYLIS GLOMERATA POLLEN 300 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | POA PRATENSIS POLLEN 100 [IR]/1; DACTYLIS GLOMERATA POLLEN 100 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 100 [IR]/1; LOLIUM PERENNE POLLEN 100 [IR]/1; PHLEUM PRATENSE POLLEN 100 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | POA PRATENSIS POLLEN 300 [IR]/1; DACTYLIS GLOMERATA POLLEN 300 [IR]/1; ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1 | Jul 22, 2026 | Sep 2, 2026 |
| Stallergenes | ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; DACTYLIS GLOMERATA POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 15, 2026 | Jul 19, 2026 |
| Cenexi Hsc | ANTHOXANTHUM ODORATUM POLLEN 300 [IR]/1; DACTYLIS GLOMERATA POLLEN 300 [IR]/1; LOLIUM PERENNE POLLEN 300 [IR]/1; PHLEUM PRATENSE POLLEN 300 [IR]/1; POA PRATENSIS POLLEN 300 [IR]/1 | Jul 15, 2026 | Jul 15, 2026 |
| Stallergenes | ANTHOXANTHUM ODORATUM POLLEN 100 [IR]/1; DACTYLIS GLOMERATA POLLEN 100 [IR]/1; LOLIUM PERENNE POLLEN 100 [IR]/1; PHLEUM PRATENSE POLLEN 100 [IR]/1; POA PRATENSIS POLLEN 100 [IR]/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Oralair 300 IR — NDC 59617-0016-01," retrieved September 3, 2026, https://drugdashboards.com/drug/59617001601.
Free to cite with attribution — see how the data is put together.